Incyte Presents New Oncology Data at ESMO Congress

Bitget2026/10/18 22:05

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold. Trade now!

A welcome pack worth 6200 USDT for new users! Sign up now!

Incyte will present oncology data at the European Society for Medical Oncology Congress in Madrid on Oct. 23-27, 2026.
Presentations will feature INCB161734, a KRAS G12D inhibitor, and INCA33890, a bispecific antibody; both are in ongoing Phase 3 programs.
An investor event and webcast on Oct. 26, 2026, from 2:30-4:00 p.m. ET will cover key data and portfolio updates.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Incyte Corporation published the original content used to generate this news brief via Business Wire (Ref. ID: 202610181805BIZWIRE_USPR_____20261018_BW477134) on October 18, 2026, and is solely responsible for the information contained therein.

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.

Trade now！

Incyte Presents New Oncology Data at ESMO Congress

You may also like

Crypto prices